Cargando…
Mapping the HLA-A24-restricted T-cell epitope peptide from a tumour-associated antigen HER2 / neu: possible immunotherapy for colorectal carcinomas
HER2 / neu is a potential antigen candidate for immunotherapy because of its correlation to a poor prognosis and high expressions in many kinds of epithelial tumours. Especially in the colorectal carcinomas, the higher expression of HER2 / neu is recognized in metastatic regions as well as in primar...
Autores principales: | Tanaka, H, Tsunoda, T, Nukaya, I, Sette, A, Matsuda, K, Umano, Y, Yamaue, H, Takesako, K, Tanimura, H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363616/ https://www.ncbi.nlm.nih.gov/pubmed/11139320 http://dx.doi.org/10.1054/bjoc.2000.1547 |
Ejemplares similares
-
Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53
por: Umano, Y, et al.
Publicado: (2001) -
Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer
por: SAWADA, YU, et al.
Publicado: (2014) -
Identification of HLA-A24-Restricted Novel T Cell Epitope Peptides Derived from P-Cadherin and Kinesin Family Member 20A
por: Osawa, Ryuji, et al.
Publicado: (2012) -
P17-24. Interfering overlapping epitopes contribute to the subdominance of an HLA-A2-restricted HIV Gag-specific epitope
por: Kan-Mitchell, J, et al.
Publicado: (2009) -
Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer
por: Tsukagoshi, Mariko, et al.
Publicado: (2018)